Applied Materials, Inc. is the world's largest semiconductor equipment company by revenue, supplying the manufacturing tools, services, and software that chipmakers use to produce integrated circuits. The company operates through three segments: Semiconductor Systems (deposit, etch, CMP, implant, inspection — the core equipment business), Applied Global Services (spares, upgrades, service contracts, and factory automation software), and Display & Adjacent Markets (thin-film deposition for OLED and LCD panels).
AMAT's equipment is embedded in every major logic and memory fabrication node. As chipmakers push toward gate-all-around (GAA) transistors, backside power delivery, and advanced packaging, the number of process steps per wafer increases — directly expanding AMAT's served market. The company holds leading positions in CVD, PVD, ALD, CMP, and ion implantation, covering an estimated 22-25% of total wafer fabrication equipment (WFE) spending globally.
Customers include TSMC, Samsung, Intel, Micron, SK Hynix, and virtually every other major IDM and foundry worldwide. Revenue is geographically diverse, with China historically representing 30%+ of revenue before export control headwinds. The AGS segment provides recurring revenue that cushions equipment cycle downturns.
Investment Thesis
Applied Materials is the dominant incumbent in semiconductor equipment at a moment when process complexity is accelerating structurally. The transition to GAA transistors (TSMC N2, Intel 14A, Samsung SF2) and high-bandwidth memory (HBM3e/HBM4) for AI accelerators requires more deposition, planarization, and inspection steps per chip — all areas where AMAT leads. This multiplies WFE intensity regardless of unit volumes.
Bull drivers: Analyst consensus sees FY2026E revenue of $31.4B (+10.8% YoY) and FY2027E of $37.7B (+19.9% YoY) as WFE spending recovers. The AGS segment is now ~27% of revenue and growing, providing margin stability. AMAT's DRAM ecosystem plays are gaining traction as HBM becomes a mainstream AI substrate. New CVD materials (EPIC system) extend AMAT's differentiation into gate-all-around era.
Key risks: The stock is pricing in a strong WFE recovery at 45.7x TTM earnings. China export controls have already cost meaningful revenue. Memory capex is volatile. At $395 vs. a 12-month analyst average of $326, the stock has re-rated well ahead of earnings and warrants caution on timing.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $23.06B | $25.79B | $26.52B | $27.18B | $28.37B |
| Revenue Growth | +34.0% | +11.8% | +2.8% | +2.5% | +4.4% |
| COGS | $12.15B | $13.79B | $14.13B | $14.28B | $14.56B |
| Gross Profit | $10.91B | $11.99B | $12.38B | $12.90B | $13.81B |
| Gross Margin | 47.3% | 46.5% | 46.7% | 47.5% | 48.7% |
| R&D Expense | $2.48B | $2.77B | $3.10B | $3.23B | $3.57B |
| SG&A Expense | $1.23B | $1.44B | $1.63B | $1.80B | $1.77B |
| Operating Income | $6.89B | $7.79B | $7.65B | $7.87B | $8.29B |
| Operating Margin | 29.9% | 30.2% | 28.8% | 29.0% | 29.2% |
| Net Income | $5.89B | $6.53B | $6.86B | $7.18B | $7.00B |
| EPS (Diluted) | $6.40 | $7.44 | $8.11 | $8.61 | $8.66 |
| Shares Outstanding (Diluted) | 919M | 877M | 845M | 834M | 808M |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & ST Investments | $5.46B | $2.58B | $6.87B | $9.47B | $8.57B |
| Total Assets | $25.82B | $26.73B | $30.73B | $34.41B | $36.30B |
| Total Debt | $5.45B | $5.46B | $5.56B | $6.26B | $6.56B |
| Net Debt / (Cash) | $0.00B | $2.88B | -$1.31B | -$3.21B | -$2.02B |
| Total Liabilities | $13.58B | $14.53B | $14.38B | $15.41B | $15.88B |
| Stockholders' Equity | $12.25B | $12.19B | $16.35B | $19.00B | $20.42B |
| Book Value / Share | $13.33 | $13.90 | $19.35 | $22.78 | $25.27 |
| Current Ratio | 2.54x | 2.16x | 2.60x | 2.51x | 2.61x |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $5.44B | $5.40B | $8.70B | $8.68B | $7.96B |
| Capital Expenditures | -$0.67B | -$0.79B | -$1.11B | -$1.19B | -$2.26B |
| Free Cash Flow | $4.77B | $4.61B | $7.59B | $7.49B | $5.70B |
| FCF Margin | 20.7% | 17.9% | 28.6% | 27.6% | 20.1% |
| Dividends Paid | -$0.84B | -$0.87B | -$0.97B | -$1.19B | -$1.38B |
| Share Buybacks | -$3.75B | -$6.10B | -$2.19B | -$3.82B | -$4.89B |
| Stock-Based Comp | $0.35B | $0.41B | $0.49B | $0.58B | $0.65B |
| Net Debt Issuance | — | — | — | $0.80B | $0.29B |
| Multiple | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 (Current Price) |
|---|---|---|---|---|---|
| P/E Ratio | 21.6x | 11.8x | 16.1x | 21.3x | 45.7x |
| P/S Ratio | 5.50x | 2.98x | 4.15x | 5.64x | 11.27x |
| P/B Ratio | 10.4x | 6.3x | 6.7x | 8.1x | 15.7x |
| P/FCF Ratio | 26.6x | 16.7x | 14.5x | 20.5x | 56.1x |
| EV/EBITDA | 17.3x | 9.8x | 13.0x | 17.3x | 32.9x |
| EV/Sales | 5.54x | 3.13x | 4.15x | 5.59x | 11.20x |
| FCF Yield | 3.76% | 6.0% | 6.9% | 4.88% | 1.78% |
| Dividend Yield | 0.61% | 1.13% | 0.88% | 0.65% | 0.46% |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Return on Equity | 48.1% | 53.5% | 41.9% | 37.8% | 34.3% |
| Return on Assets | 22.8% | 24.4% | 22.3% | 20.9% | 19.3% |
| ROIC | 30.6% | 34.4% | 28.8% | 25.8% | 22.0% |
| Asset Turnover | 0.89x | 0.96x | 0.86x | 0.79x | 0.78x |
| Current Ratio | 2.54x | 2.16x | 2.60x | 2.51x | 2.61x |
| Inventory Turnover | 2.60x | 2.55x | 2.48x | 2.49x | 2.46x |
| Days Sales Outstanding | 72.4 | 75.1 | 68.2 | 67.8 | 68.6 |
| Metric | FY2025A | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|---|
| Revenue (Avg) | $28.37B | $31.43B | $37.67B | $41.39B | $44.07B |
| Rev Growth | +4.4% | +10.8% | +19.9% | +9.9% | +6.5% |
| EPS (Avg) | $8.66 | $11.05 | $14.05 | $15.61 | $17.79 |
| EPS Growth | +0.6% | +27.6% | +27.1% | +11.1% | +14.0% |
| # Analysts (Rev) | — | 25 | 24 | 13 | 6 |
| Fwd P/E | 45.7x | 35.8x | 28.2x | 25.4x | 22.2x |
| Name | Title | Type | Shares | Est. Price | Date |
|---|---|---|---|---|---|
| Gary E. Dickerson | President & CEO | Tax W/H | ~12,400 | ~$365 | Mar 2026 |
| Brice Hill | EVP & CFO | Tax W/H | ~4,800 | ~$365 | Mar 2026 |
| Prabu Raja | EVP, SSBU | Tax W/H | ~6,200 | ~$360 | Mar 2026 |
| Thomas Larkins | EVP, General Counsel | Tax W/H | ~3,100 | ~$355 | Feb 2026 |
| Gary E. Dickerson | President & CEO | Sale | ~25,000 | ~$340-370 | Feb 2026 |
WFE supercycle driven by AI and advanced logic. The ramp of gate-all-around transistors at TSMC, Samsung, and Intel requires significantly more deposition steps per wafer than FinFET. AMAT's CVD and ALD tools are embedded in each transition. Combined with HBM4 capacity expansion for AI chips, WFE intensity per dollar of capex structurally improves.
Services segment provides recession buffer and re-rates multiple. The Applied Global Services segment (AGS) is a $7B+ run-rate business with 50%+ gross margins and multi-year service contracts. As the installed base grows, AGS should compound at 8-10% annually regardless of equipment spending cycles — this creates a floor for earnings and supports a higher blended multiple.
EPS trajectory is steep. Analysts expect FY2026E EPS of $11.05 (+27.6% YoY) and FY2027E of $14.05 (+27.1%). At the FY2027 forward P/E of 28x, the stock would be fairly valued at $393 — roughly in line with current levels, leaving upside to further estimate revisions or multiple expansion if the WFE recovery is stronger than expected.
Capital returns remain shareholder-friendly. AMAT has bought back $21B+ in shares over five years, reducing diluted share count from 919M to 808M. The $1.84 annual dividend has grown every year.
Valuation has re-rated far ahead of fundamentals. The stock trades at 45.7x TTM earnings and 56x TTM FCF — near historic highs — while the 12-month consensus price target average of $326 implies the stock is already 21% overvalued relative to analyst models. The recent spike from $133 to $407 in 12 months is extraordinary and assumes significant WFE recovery that has not yet materialized in results.
China export controls are a structural headwind. China historically represented 30%+ of AMAT revenue. US restrictions on advanced semiconductor equipment exports have already curtailed this access, and further tightening is likely. This is not a cyclical issue — it is a permanent reduction in addressable market, requiring the rest of the world to compensate.
FCF declined in FY2025 despite revenue growth. FCF fell from $7.49B to $5.70B as CapEx more than doubled (from $1.19B to $2.26B). This investment is necessary but compresses near-term returns. At current prices, FCF yield is only 1.78% — leaving little margin of safety.
Memory capex is lumpy and customer concentration is high. DRAM and NAND capex remains volatile and subject to Samsung/Micron/SK Hynix investment cycles. Any delay in capacity expansion by one major customer creates outsized revenue risk given AMAT's customer concentration.
US restrictions on advanced semiconductor equipment exports to China have permanently reduced AMAT's addressable market. BIS rule updates could expand restrictions to additional technologies (e.g., ALD for DRAM). China revenue recovery is uncertain and any re-escalation creates immediate revenue risk.
Semiconductor equipment spending is highly cyclical. FY2023-2024 was a down-cycle; consensus anticipates recovery in FY2026-2027. If macroeconomic weakness delays fab investment or if hyperscaler AI capex is redirected toward compute rather than leading-edge logic, AMAT's revenue recovery timeline extends significantly.
At 45.7x TTM earnings and 32.9x EV/EBITDA, AMAT is priced well above its historical midcycle average. Any miss versus consensus estimates, guide-down, or broader semiconductor sector derating could result in significant multiple compression. The 1.64 beta amplifies volatility during risk-off episodes.
TSMC, Samsung, and Intel collectively drive a majority of equipment orders. TSMC alone likely represents 20%+ of AMAT revenues. Investment pauses, supply chain disruptions, or technology transitions at any of these customers create outsized quarterly revenue swings that the market punishes severely.
AMAT is investing heavily in its own infrastructure (R&D labs, advanced packaging centers) to stay ahead of next-generation process requirements. FY2025 CapEx doubled to $2.26B. If sustained, this permanently reduces FCF conversion, which at current P/FCF of 56x leaves little cushion versus expectations.
ASML, Lam Research, KLA, and Tokyo Electron compete across AMAT's core product areas. ASML's EUV monopoly creates a counterweight in the equipment ecosystem. Emerging Chinese equipment makers (NAURA, AMEC) are gaining capability in mature nodes, eroding the China opportunity that may return under different trade regimes.
WFE spending accelerates beyond consensus. Gate-all-around ramp at TSMC N2 drives tooling orders above $33B in FY2026. China restrictions ease partially. FY2027E EPS beats to $16-17, justifying 30x earnings at $500.
Revenue tracks consensus at $31.4B in FY2026 and $37.7B in FY2027. EPS hits $14 by FY2027. Multiple stays around 28-30x forward earnings as cyclical recovery remains on track. Roughly in line with last-quarter avg PT of $413.81.
WFE recovery delayed by macro headwinds and China restrictions tighten further. FY2026 revenue disappoints at $28-29B. Multiple compresses to 20-22x earnings (~$11 EPS), consistent with the 12-month avg analyst PT of $326.
| Metric | Base (FY2025) | FY2026 | FY2027 | FY2028 | FY2029 | FY2030 | FY2031 | FY2032 | Terminal |
|---|
Model type: 7-year unlevered free cash flow DCF with Gordon Growth terminal value. All values in USD millions.
Base year: Fiscal Year 2025 (ended October 26, 2025). Revenue: $28.37B. Operating Cash Flow: $7.96B. Free Cash Flow: $5.70B (OCF $7.96B minus CapEx $2.26B). Note that FY2025 FCF declined YoY due to elevated CapEx investment in R&D infrastructure and advanced packaging capability.
Revenue assumptions: Years 1-2 reflect analyst consensus estimates ($31.4B FY2026, $37.7B FY2027). Years 3-7 taper growth from 9.9% toward 4% as WFE spending growth matures and AMAT's market share stabilizes. Default scenario assumes AMAT captures its proportional share of a robust but non-supercycle WFE environment.
Margin assumptions: OCF margin defaults to 28.1% (FY2025 actual). CapEx/Revenue at 8.0% (FY2025 actual, elevated due to infrastructure investment). Terminal FCF margin of 22% assumes CapEx normalizes to ~6% of revenue as major infrastructure build-outs complete. The AGS segment's growing mix should support margin improvement over the forecast period.
WACC: Derived from CAPM with 1.64 beta (FMP profile), 4.3% risk-free rate (10-year Treasury), 5.5% equity risk premium. Cost of debt approximately 4.2% (interest expense / average debt). Debt weight D/(D+E) of 2% reflects AMAT's near-net-cash balance sheet. Resulting WACC of approximately 13.3% is appropriate for a semiconductor equipment company with cyclical revenues.
Caveats: The DCF is highly sensitive to terminal growth rate and WACC assumptions. At current prices (~$395), the implied FCF yield of 1.78% and the growth implied by the market price require strong conviction in the WFE recovery thesis. Users should sensitivity-test by reducing CapEx/Rev to 5-6% (normalized) to see the upside scenario where FCF margins recover to 22-25%. China export control resolution or further restriction represents the most significant binary risk not captured in base assumptions.
This report was generated using FMP financial data as of April 13, 2026. Interactive DCF model included. All inputs are adjustable. This is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.